Interpretation of the main updates of the NCCN clinical practice guidelines for esophageal and esophagogastric junction cancer (version 1.2023)
- VernacularTitle:《NCCN食管和食管胃结合部癌临床实践指南（2023 V1版）》更新解读
- Author:
Ping ZHANG
1
;
Quanbing SU
1
;
Jun WANG
1
Author Information
1. The First Ward of Thoracic Radiotherapy, The Fourth Hospital of Hebei Medical University, Shijiazhuang, 050000, P. R. China
- Publication Type:Journal Article
- Keywords:
Esophageal cancer;
esophagogastric junction cancer;
NCCN guideline;
interpretation of the main updatets
- From:
Chinese Journal of Clinical Thoracic and Cardiovascular Surgery
2023;30(07):939-944
- CountryChina
- Language:Chinese
-
Abstract:
Upper gastrointestinal tract cancers originating in the esophagus or esophagogastric junction constitute a major global health problem. On February 28, 2023, National Comprehensive Cancer Network (NCCN) released the clinical practice guidelines for esophageal and esophagogastric junction cancer (version 1.2023). This article will interpret the main updates related to the treatment and follow-up in this version compared to the version 5.2022, in order to provide the Chinese clinicians a better basis and reference for the diagnosis and treatment of the diseases.
